fak py397 Search Results


anti-fak(py397  (Enzo Biochem)
90
Enzo Biochem anti-fak(py397
Anti Fak(Py397, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-fak(py397/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
anti-fak(py397 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibodies against fak-py-397  (Biomol GmbH)
90
Biomol GmbH primary antibodies against fak-py-397
Primary Antibodies Against Fak Py 397, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against fak-py-397/product/Biomol GmbH
Average 90 stars, based on 1 article reviews
primary antibodies against fak-py-397 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
ham's f12 media without phenol red  (United BioSource)
90
United BioSource ham's f12 media without phenol red
Ham's F12 Media Without Phenol Red, supplied by United BioSource, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ham's f12 media without phenol red/product/United BioSource
Average 90 stars, based on 1 article reviews
ham's f12 media without phenol red - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
fak py397 antibody  (ABclonal Biotechnology)
90
ABclonal Biotechnology fak py397 antibody
LOXL1 catalytic domain (CD) promotes angiogenesis of VECs by activating the <t>FAK</t> and MAPK signaling pathway (A) Schematic illustration of LOXL1 structure: LOXL1 full-length was divided into five fragments for further purification: F0 (full-length protein), F1 (truncation of signal peptide, spanning residues 26−574 aa), F2 (truncation of both signal and pro-peptides, spanning residues 95−574 aa), F3 (middle fragment, residues 106−574 aa), and F4 (CD, residues 367−574 aa). (B) DNA electrophoresis of five fragments. (C) Purification of GST-LOXL1 CD by passing through a GST column. (D) Identification of GST-LOXL1 CD by HRV 3C protease digestion. (E) Purification of GST-LOXL1 CD by passing through a size-exclusion chromatography column. (F) GST-LOXL1 CD (wild-type [WT]) promoted angiogenesis of VECs compared to GST and GST-LOXL1 CD H449/H451A (mutant). Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (G) <t>pFAK</t> <t>pY861</t> and pErk1/2 in VECs was upregulated by GST-LOXL1 CD .
Fak Py397 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fak py397 antibody/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
fak py397 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
py397 surrounding tyr-397 fak (setddpyaeiide  (Mimotopes)
90
Mimotopes py397 surrounding tyr-397 fak (setddpyaeiide
LOXL1 catalytic domain (CD) promotes angiogenesis of VECs by activating the <t>FAK</t> and MAPK signaling pathway (A) Schematic illustration of LOXL1 structure: LOXL1 full-length was divided into five fragments for further purification: F0 (full-length protein), F1 (truncation of signal peptide, spanning residues 26−574 aa), F2 (truncation of both signal and pro-peptides, spanning residues 95−574 aa), F3 (middle fragment, residues 106−574 aa), and F4 (CD, residues 367−574 aa). (B) DNA electrophoresis of five fragments. (C) Purification of GST-LOXL1 CD by passing through a GST column. (D) Identification of GST-LOXL1 CD by HRV 3C protease digestion. (E) Purification of GST-LOXL1 CD by passing through a size-exclusion chromatography column. (F) GST-LOXL1 CD (wild-type [WT]) promoted angiogenesis of VECs compared to GST and GST-LOXL1 CD H449/H451A (mutant). Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (G) <t>pFAK</t> <t>pY861</t> and pErk1/2 in VECs was upregulated by GST-LOXL1 CD .
Py397 Surrounding Tyr 397 Fak (Setddpyaeiide, supplied by Mimotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/py397 surrounding tyr-397 fak (setddpyaeiide/product/Mimotopes
Average 90 stars, based on 1 article reviews
py397 surrounding tyr-397 fak (setddpyaeiide - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
phosphospecific fak py397 pab antibody  (Upstate Group Inc)
90
Upstate Group Inc phosphospecific fak py397 pab antibody
LOXL1 catalytic domain (CD) promotes angiogenesis of VECs by activating the <t>FAK</t> and MAPK signaling pathway (A) Schematic illustration of LOXL1 structure: LOXL1 full-length was divided into five fragments for further purification: F0 (full-length protein), F1 (truncation of signal peptide, spanning residues 26−574 aa), F2 (truncation of both signal and pro-peptides, spanning residues 95−574 aa), F3 (middle fragment, residues 106−574 aa), and F4 (CD, residues 367−574 aa). (B) DNA electrophoresis of five fragments. (C) Purification of GST-LOXL1 CD by passing through a GST column. (D) Identification of GST-LOXL1 CD by HRV 3C protease digestion. (E) Purification of GST-LOXL1 CD by passing through a size-exclusion chromatography column. (F) GST-LOXL1 CD (wild-type [WT]) promoted angiogenesis of VECs compared to GST and GST-LOXL1 CD H449/H451A (mutant). Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (G) <t>pFAK</t> <t>pY861</t> and pErk1/2 in VECs was upregulated by GST-LOXL1 CD .
Phosphospecific Fak Py397 Pab Antibody, supplied by Upstate Group Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphospecific fak py397 pab antibody/product/Upstate Group Inc
Average 90 stars, based on 1 article reviews
phosphospecific fak py397 pab antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
anti-py397 fak  (GenScript corporation)
90
GenScript corporation anti-py397 fak
LOXL1 catalytic domain (CD) promotes angiogenesis of VECs by activating the <t>FAK</t> and MAPK signaling pathway (A) Schematic illustration of LOXL1 structure: LOXL1 full-length was divided into five fragments for further purification: F0 (full-length protein), F1 (truncation of signal peptide, spanning residues 26−574 aa), F2 (truncation of both signal and pro-peptides, spanning residues 95−574 aa), F3 (middle fragment, residues 106−574 aa), and F4 (CD, residues 367−574 aa). (B) DNA electrophoresis of five fragments. (C) Purification of GST-LOXL1 CD by passing through a GST column. (D) Identification of GST-LOXL1 CD by HRV 3C protease digestion. (E) Purification of GST-LOXL1 CD by passing through a size-exclusion chromatography column. (F) GST-LOXL1 CD (wild-type [WT]) promoted angiogenesis of VECs compared to GST and GST-LOXL1 CD H449/H451A (mutant). Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (G) <t>pFAK</t> <t>pY861</t> and pErk1/2 in VECs was upregulated by GST-LOXL1 CD .
Anti Py397 Fak, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-py397 fak/product/GenScript corporation
Average 90 stars, based on 1 article reviews
anti-py397 fak - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
ec_py397-fak  (Angiocrine)
90
Angiocrine ec_py397-fak
LOXL1 catalytic domain (CD) promotes angiogenesis of VECs by activating the <t>FAK</t> and MAPK signaling pathway (A) Schematic illustration of LOXL1 structure: LOXL1 full-length was divided into five fragments for further purification: F0 (full-length protein), F1 (truncation of signal peptide, spanning residues 26−574 aa), F2 (truncation of both signal and pro-peptides, spanning residues 95−574 aa), F3 (middle fragment, residues 106−574 aa), and F4 (CD, residues 367−574 aa). (B) DNA electrophoresis of five fragments. (C) Purification of GST-LOXL1 CD by passing through a GST column. (D) Identification of GST-LOXL1 CD by HRV 3C protease digestion. (E) Purification of GST-LOXL1 CD by passing through a size-exclusion chromatography column. (F) GST-LOXL1 CD (wild-type [WT]) promoted angiogenesis of VECs compared to GST and GST-LOXL1 CD H449/H451A (mutant). Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (G) <t>pFAK</t> <t>pY861</t> and pErk1/2 in VECs was upregulated by GST-LOXL1 CD .
Ec Py397 Fak, supplied by Angiocrine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ec_py397-fak/product/Angiocrine
Average 90 stars, based on 1 article reviews
ec_py397-fak - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
rabbit anti-py397 fak  (Fisher Scientific)
90
Fisher Scientific rabbit anti-py397 fak
LOXL1 catalytic domain (CD) promotes angiogenesis of VECs by activating the <t>FAK</t> and MAPK signaling pathway (A) Schematic illustration of LOXL1 structure: LOXL1 full-length was divided into five fragments for further purification: F0 (full-length protein), F1 (truncation of signal peptide, spanning residues 26−574 aa), F2 (truncation of both signal and pro-peptides, spanning residues 95−574 aa), F3 (middle fragment, residues 106−574 aa), and F4 (CD, residues 367−574 aa). (B) DNA electrophoresis of five fragments. (C) Purification of GST-LOXL1 CD by passing through a GST column. (D) Identification of GST-LOXL1 CD by HRV 3C protease digestion. (E) Purification of GST-LOXL1 CD by passing through a size-exclusion chromatography column. (F) GST-LOXL1 CD (wild-type [WT]) promoted angiogenesis of VECs compared to GST and GST-LOXL1 CD H449/H451A (mutant). Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (G) <t>pFAK</t> <t>pY861</t> and pErk1/2 in VECs was upregulated by GST-LOXL1 CD .
Rabbit Anti Py397 Fak, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-py397 fak/product/Fisher Scientific
Average 90 stars, based on 1 article reviews
rabbit anti-py397 fak - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


LOXL1 catalytic domain (CD) promotes angiogenesis of VECs by activating the FAK and MAPK signaling pathway (A) Schematic illustration of LOXL1 structure: LOXL1 full-length was divided into five fragments for further purification: F0 (full-length protein), F1 (truncation of signal peptide, spanning residues 26−574 aa), F2 (truncation of both signal and pro-peptides, spanning residues 95−574 aa), F3 (middle fragment, residues 106−574 aa), and F4 (CD, residues 367−574 aa). (B) DNA electrophoresis of five fragments. (C) Purification of GST-LOXL1 CD by passing through a GST column. (D) Identification of GST-LOXL1 CD by HRV 3C protease digestion. (E) Purification of GST-LOXL1 CD by passing through a size-exclusion chromatography column. (F) GST-LOXL1 CD (wild-type [WT]) promoted angiogenesis of VECs compared to GST and GST-LOXL1 CD H449/H451A (mutant). Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (G) pFAK pY861 and pErk1/2 in VECs was upregulated by GST-LOXL1 CD .

Journal: Molecular Therapy. Nucleic Acids

Article Title: LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC

doi: 10.1016/j.omtn.2021.01.001

Figure Lengend Snippet: LOXL1 catalytic domain (CD) promotes angiogenesis of VECs by activating the FAK and MAPK signaling pathway (A) Schematic illustration of LOXL1 structure: LOXL1 full-length was divided into five fragments for further purification: F0 (full-length protein), F1 (truncation of signal peptide, spanning residues 26−574 aa), F2 (truncation of both signal and pro-peptides, spanning residues 95−574 aa), F3 (middle fragment, residues 106−574 aa), and F4 (CD, residues 367−574 aa). (B) DNA electrophoresis of five fragments. (C) Purification of GST-LOXL1 CD by passing through a GST column. (D) Identification of GST-LOXL1 CD by HRV 3C protease digestion. (E) Purification of GST-LOXL1 CD by passing through a size-exclusion chromatography column. (F) GST-LOXL1 CD (wild-type [WT]) promoted angiogenesis of VECs compared to GST and GST-LOXL1 CD H449/H451A (mutant). Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (G) pFAK pY861 and pErk1/2 in VECs was upregulated by GST-LOXL1 CD .

Article Snippet: Flag-tag, FBLN5, FAK pY861, FAK pY397, and FAK (ABclonal, China) antibodies were used as primary antibodies to examine protein expressions.

Techniques: Purification, Nucleic Acid Electrophoresis, Size-exclusion Chromatography, Mutagenesis

RGD domain in FBLN5 is indispensable to the proangiogenic function of LOXL1 in ICC by binding to the αvβ3 integrin (A) pUC57, pFBLN5 RGD , and pFBLN5 RGE were transfected into RBE cells, and the efficiency of transfection was measured by western blot. A higher level of FBLN5 protein was contained in the supernatant of pFBLN5 transfected groups compared to pUC57 groups. (B and C) The roles of RGD domain and the αvβ3 integrin in the proangiogenic process of GST-LOXL1 CD were detected through tube-formation assays. Cyclo (-RGDfK) (50 ng/μL) was used to block the αvβ3 integrin. Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (D) Cell lysates of VECs were collected for testing phosphorylation levels of FAK and Erk1/2 by western blot. (E) Colocalization of LOXL1, FBLN5, and the αvβ3 integrin along with the vessel-like structure in the extracellular matrix of ICC tumor tissues. Scale bars, 100 μm.

Journal: Molecular Therapy. Nucleic Acids

Article Title: LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC

doi: 10.1016/j.omtn.2021.01.001

Figure Lengend Snippet: RGD domain in FBLN5 is indispensable to the proangiogenic function of LOXL1 in ICC by binding to the αvβ3 integrin (A) pUC57, pFBLN5 RGD , and pFBLN5 RGE were transfected into RBE cells, and the efficiency of transfection was measured by western blot. A higher level of FBLN5 protein was contained in the supernatant of pFBLN5 transfected groups compared to pUC57 groups. (B and C) The roles of RGD domain and the αvβ3 integrin in the proangiogenic process of GST-LOXL1 CD were detected through tube-formation assays. Cyclo (-RGDfK) (50 ng/μL) was used to block the αvβ3 integrin. Scale bars, 100 μm (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (D) Cell lysates of VECs were collected for testing phosphorylation levels of FAK and Erk1/2 by western blot. (E) Colocalization of LOXL1, FBLN5, and the αvβ3 integrin along with the vessel-like structure in the extracellular matrix of ICC tumor tissues. Scale bars, 100 μm.

Article Snippet: Flag-tag, FBLN5, FAK pY861, FAK pY397, and FAK (ABclonal, China) antibodies were used as primary antibodies to examine protein expressions.

Techniques: Binding Assay, Transfection, Western Blot, Blocking Assay, Phospho-proteomics